HEADER HYDROLASE 06-OCT-04 1XOT
TITLE CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH
TITLE 2 VARDENAFIL
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B;
COMPND 3 CHAIN: B, A;
COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B;
COMPND 5 SYNONYM: DPDE4, PDE32;
COMPND 6 EC: 3.1.4.17;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PDE4B;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)CODON PLUS(RIL);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B
KEYWDS PHOSPHODIESTERASE, PDE, PDE4B, VARDENAFIL, LEVITRA, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU,
AUTHOR 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG,M.V.MILBURN,
AUTHOR 3 S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG
REVDAT 4 13-NOV-24 1XOT 1 REMARK SEQADV LINK
REVDAT 3 13-JUL-11 1XOT 1 VERSN
REVDAT 2 24-FEB-09 1XOT 1 VERSN
REVDAT 1 14-DEC-04 1XOT 0
JRNL AUTH G.L.CARD,B.P.ENGLAND,Y.SUZUKI,D.FONG,B.POWELL,B.LEE,C.LUU,
JRNL AUTH 2 M.TABRIZIZAD,S.GILLETTE,P.N.IBRAHIM,D.R.ARTIS,G.BOLLAG,
JRNL AUTH 3 M.V.MILBURN,S.-H.KIM,J.SCHLESSINGER,K.Y.J.ZHANG
JRNL TITL STRUCTURAL BASIS FOR THE ACTIVITY OF DRUGS THAT INHIBIT
JRNL TITL 2 PHOSPHODIESTERASES.
JRNL REF STRUCTURE V. 12 2233 2004
JRNL REFN ISSN 0969-2126
JRNL PMID 15576036
JRNL DOI 10.1016/J.STR.2004.10.004
REMARK 2
REMARK 2 RESOLUTION. 2.34 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.1.25
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.71
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 NUMBER OF REFLECTIONS : 37567
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.213
REMARK 3 R VALUE (WORKING SET) : 0.210
REMARK 3 FREE R VALUE : 0.259
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 2002
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.34
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2742
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : 0.3210
REMARK 3 BIN FREE R VALUE SET COUNT : 149
REMARK 3 BIN FREE R VALUE : 0.3800
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5234
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 72
REMARK 3 SOLVENT ATOMS : 46
REMARK 3
REMARK 3 B VALUES.
REMARK 3 B VALUE TYPE : LIKELY RESIDUAL
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.73
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -5.42000
REMARK 3 B22 (A**2) : 1.01000
REMARK 3 B33 (A**2) : 4.41000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.288
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.233
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.201
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.063
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5410 ; 0.018 ; 0.021
REMARK 3 BOND LENGTHS OTHERS (A): 4808 ; 0.002 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7344 ; 1.703 ; 1.954
REMARK 3 BOND ANGLES OTHERS (DEGREES): 11196 ; 0.980 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 644 ; 3.292 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 828 ; 0.118 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5946 ; 0.009 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): 1054 ; 0.007 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1279 ; 0.217 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5479 ; 0.220 ; 0.200
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): 3126 ; 0.096 ; 0.200
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 94 ; 0.147 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 4 ; 0.145 ; 0.200
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.139 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): 28 ; 0.327 ; 0.200
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.135 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3228 ; 0.597 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5234 ; 1.142 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2182 ; 2.008 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2110 ; 3.121 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 2
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 163 B 193
REMARK 3 RESIDUE RANGE : B 195 B 485
REMARK 3 ORIGIN FOR THE GROUP (A): 42.5819 2.6407 52.9873
REMARK 3 T TENSOR
REMARK 3 T11: 0.2516 T22: 0.1239
REMARK 3 T33: 0.1860 T12: 0.0265
REMARK 3 T13: 0.0533 T23: 0.1510
REMARK 3 L TENSOR
REMARK 3 L11: 5.6476 L22: 1.6120
REMARK 3 L33: 3.6253 L12: -0.6660
REMARK 3 L13: -0.8991 L23: 0.0170
REMARK 3 S TENSOR
REMARK 3 S11: -0.0780 S12: 0.0031 S13: -0.1635
REMARK 3 S21: -0.0876 S22: -0.1692 S23: -0.1144
REMARK 3 S31: 0.1376 S32: 0.3843 S33: 0.2472
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 2
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 163 A 193
REMARK 3 RESIDUE RANGE : A 195 A 485
REMARK 3 ORIGIN FOR THE GROUP (A): 2.3566 2.1201 53.1913
REMARK 3 T TENSOR
REMARK 3 T11: 0.3063 T22: 0.1332
REMARK 3 T33: 0.0952 T12: -0.0104
REMARK 3 T13: 0.0743 T23: -0.0016
REMARK 3 L TENSOR
REMARK 3 L11: 5.1042 L22: 1.4134
REMARK 3 L33: 3.1546 L12: 0.4028
REMARK 3 L13: -0.1675 L23: 0.0822
REMARK 3 S TENSOR
REMARK 3 S11: -0.0661 S12: 0.1883 S13: -0.5234
REMARK 3 S21: -0.0015 S22: -0.0470 S23: 0.0510
REMARK 3 S31: 0.1704 S32: -0.2728 S33: 0.1131
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 1XOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-NOV-04.
REMARK 100 THE DEPOSITION ID IS D_1000030591.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 08-AUG-03
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : 10.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 8.3.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE
REMARK 200 DATA SCALING SOFTWARE : ELVES
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37567
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340
REMARK 200 RESOLUTION RANGE LOW (A) : 70.710
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 200 DATA REDUNDANCY : 4.000
REMARK 200 R MERGE (I) : 0.07400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 4.10
REMARK 200 R MERGE FOR SHELL (I) : 0.91900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.300
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: EPMR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 51.22
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE AND LITHIUM SULFATE ,
REMARK 280 PH 10.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 44.92050
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.37750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.21150
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.37750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.92050
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.21150
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS ONE MONOMER.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET B 131
REMARK 465 GLY B 132
REMARK 465 SER B 133
REMARK 465 SER B 134
REMARK 465 HIS B 135
REMARK 465 HIS B 136
REMARK 465 HIS B 137
REMARK 465 HIS B 138
REMARK 465 HIS B 139
REMARK 465 HIS B 140
REMARK 465 SER B 141
REMARK 465 SER B 142
REMARK 465 GLY B 143
REMARK 465 LEU B 144
REMARK 465 VAL B 145
REMARK 465 PRO B 146
REMARK 465 ARG B 147
REMARK 465 GLY B 148
REMARK 465 SER B 149
REMARK 465 HIS B 150
REMARK 465 MET B 151
REMARK 465 SER B 152
REMARK 465 ILE B 153
REMARK 465 SER B 154
REMARK 465 ARG B 155
REMARK 465 PHE B 156
REMARK 465 GLY B 157
REMARK 465 VAL B 158
REMARK 465 ASN B 159
REMARK 465 THR B 160
REMARK 465 GLU B 161
REMARK 465 ASN B 162
REMARK 465 GLN B 486
REMARK 465 SER B 487
REMARK 465 PRO B 488
REMARK 465 SER B 489
REMARK 465 PRO B 490
REMARK 465 PRO B 491
REMARK 465 LEU B 492
REMARK 465 ASP B 493
REMARK 465 GLU B 494
REMARK 465 GLN B 495
REMARK 465 ASN B 496
REMARK 465 ARG B 497
REMARK 465 ASP B 498
REMARK 465 CYS B 499
REMARK 465 GLN B 500
REMARK 465 GLY B 501
REMARK 465 LEU B 502
REMARK 465 MET B 503
REMARK 465 GLU B 504
REMARK 465 LYS B 505
REMARK 465 PHE B 506
REMARK 465 GLN B 507
REMARK 465 PHE B 508
REMARK 465 GLU B 509
REMARK 465 LEU B 510
REMARK 465 THR B 511
REMARK 465 LEU B 512
REMARK 465 ASP B 513
REMARK 465 GLU B 514
REMARK 465 GLU B 515
REMARK 465 ASP B 516
REMARK 465 SER B 517
REMARK 465 GLU B 518
REMARK 465 GLY B 519
REMARK 465 PRO B 520
REMARK 465 GLU B 521
REMARK 465 LYS B 522
REMARK 465 GLU B 523
REMARK 465 GLY B 524
REMARK 465 GLU B 525
REMARK 465 GLY B 526
REMARK 465 HIS B 527
REMARK 465 SER B 528
REMARK 465 MET A 131
REMARK 465 GLY A 132
REMARK 465 SER A 133
REMARK 465 SER A 134
REMARK 465 HIS A 135
REMARK 465 HIS A 136
REMARK 465 HIS A 137
REMARK 465 HIS A 138
REMARK 465 HIS A 139
REMARK 465 HIS A 140
REMARK 465 SER A 141
REMARK 465 SER A 142
REMARK 465 GLY A 143
REMARK 465 LEU A 144
REMARK 465 VAL A 145
REMARK 465 PRO A 146
REMARK 465 ARG A 147
REMARK 465 GLY A 148
REMARK 465 SER A 149
REMARK 465 HIS A 150
REMARK 465 MET A 151
REMARK 465 SER A 152
REMARK 465 ILE A 153
REMARK 465 SER A 154
REMARK 465 ARG A 155
REMARK 465 PHE A 156
REMARK 465 GLY A 157
REMARK 465 VAL A 158
REMARK 465 ASN A 159
REMARK 465 THR A 160
REMARK 465 GLU A 161
REMARK 465 ASN A 162
REMARK 465 GLN A 486
REMARK 465 SER A 487
REMARK 465 PRO A 488
REMARK 465 SER A 489
REMARK 465 PRO A 490
REMARK 465 PRO A 491
REMARK 465 LEU A 492
REMARK 465 ASP A 493
REMARK 465 GLU A 494
REMARK 465 GLN A 495
REMARK 465 ASN A 496
REMARK 465 ARG A 497
REMARK 465 ASP A 498
REMARK 465 CYS A 499
REMARK 465 GLN A 500
REMARK 465 GLY A 501
REMARK 465 LEU A 502
REMARK 465 MET A 503
REMARK 465 GLU A 504
REMARK 465 LYS A 505
REMARK 465 PHE A 506
REMARK 465 GLN A 507
REMARK 465 PHE A 508
REMARK 465 GLU A 509
REMARK 465 LEU A 510
REMARK 465 THR A 511
REMARK 465 LEU A 512
REMARK 465 ASP A 513
REMARK 465 GLU A 514
REMARK 465 GLU A 515
REMARK 465 ASP A 516
REMARK 465 SER A 517
REMARK 465 GLU A 518
REMARK 465 GLY A 519
REMARK 465 PRO A 520
REMARK 465 GLU A 521
REMARK 465 LYS A 522
REMARK 465 GLU A 523
REMARK 465 GLY A 524
REMARK 465 GLU A 525
REMARK 465 GLY A 526
REMARK 465 HIS A 527
REMARK 465 SER A 528
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU B 318 CG CD OE1 OE2
REMARK 480 GLU A 318 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 GLU B 318 CB GLU B 318 CG 0.303
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ASP B 214 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES
REMARK 500 ASP B 299 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES
REMARK 500 GLU B 318 CA - CB - CG ANGL. DEV. = -19.9 DEGREES
REMARK 500 ASP B 340 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES
REMARK 500 ASP B 356 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES
REMARK 500 ASP B 392 CB - CG - OD2 ANGL. DEV. = 7.5 DEGREES
REMARK 500 ASP B 468 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES
REMARK 500 ASP A 230 CB - CG - OD2 ANGL. DEV. = 7.7 DEGREES
REMARK 500 ASP A 340 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES
REMARK 500 ASP A 375 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES
REMARK 500 ASP A 392 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES
REMARK 500 ASP A 468 CB - CG - OD2 ANGL. DEV. = 6.5 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER B 187 33.49 -143.80
REMARK 500 CME B 194 -70.86 -27.03
REMARK 500 HIS B 234 45.56 -84.09
REMARK 500 GLU B 318 -62.19 -26.14
REMARK 500 HIS B 319 20.75 -77.79
REMARK 500 ASP B 375 -86.51 -54.08
REMARK 500 LEU B 393 41.80 -108.70
REMARK 500 CME A 194 -74.32 -25.41
REMARK 500 PRO A 430 -13.72 -36.71
REMARK 500 THR A 436 -43.84 -131.91
REMARK 500 ILE A 450 -51.03 -136.29
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600 HOH 1003-1008 ARE ASSOCIATED WITH CHAIN A.
REMARK 600 HOH 2003-2008 ARE ASSOCIATED WITH CHAIN B.
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 ZN B1001 ZN
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS B 238 NE2
REMARK 620 2 HIS B 274 NE2 107.7
REMARK 620 3 ASP B 275 OD2 89.4 87.7
REMARK 620 4 ASP B 392 OD2 88.5 92.0 177.7
REMARK 620 5 HOH B2007 O 151.0 97.4 77.2 105.1
REMARK 620 6 HOH B2008 O 74.2 174.3 86.9 93.5 79.5
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG B1002 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP B 275 OD1
REMARK 620 2 HOH B2003 O 87.5
REMARK 620 3 HOH B2004 O 70.2 82.2
REMARK 620 4 HOH B2005 O 152.2 81.8 83.0
REMARK 620 5 HOH B2006 O 105.6 90.5 171.7 100.1
REMARK 620 6 HOH B2007 O 83.6 169.9 90.2 104.0 96.5
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 ZN A1001 ZN
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS A 238 NE2
REMARK 620 2 HIS A 274 NE2 99.3
REMARK 620 3 ASP A 275 OD2 87.9 91.6
REMARK 620 4 ASP A 392 OD2 89.4 86.9 176.6
REMARK 620 5 HOH A1007 O 162.1 97.5 85.7 97.5
REMARK 620 6 HOH A1008 O 86.5 174.0 90.0 91.8 76.8
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A1002 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 275 OD1
REMARK 620 2 HOH A1003 O 92.3
REMARK 620 3 HOH A1004 O 79.7 90.1
REMARK 620 4 HOH A1005 O 155.4 94.5 76.7
REMARK 620 5 HOH A1006 O 94.9 81.6 169.9 109.5
REMARK 620 6 HOH A1007 O 86.6 173.6 95.8 89.0 92.3
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1002
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1002
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VDN A 101
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VDN B 102
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1XLX RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH CILOMILAST
REMARK 900 RELATED ID: 1XLZ RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH FILAMINAST
REMARK 900 RELATED ID: 1XM4 RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH PICLAMILAST
REMARK 900 RELATED ID: 1XM6 RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH (R)-MESOPRAM
REMARK 900 RELATED ID: 1XMU RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH ROFLUMILAST
REMARK 900 RELATED ID: 1XMY RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH (R)-ROLIPRAM
REMARK 900 RELATED ID: 1XN0 RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH (R,S)-ROLIPRAM
REMARK 900 RELATED ID: 1XOM RELATED DB: PDB
REMARK 900 PDE4D IN COMPLEX WITH CILOMILAST
REMARK 900 RELATED ID: 1XON RELATED DB: PDB
REMARK 900 PDE4D IN COMPLEX WITH PICLAMILAST
REMARK 900 RELATED ID: 1XOQ RELATED DB: PDB
REMARK 900 PDE4D IN COMPLEX WITH ROFLUMILAST
REMARK 900 RELATED ID: 1XOR RELATED DB: PDB
REMARK 900 PDE4D IN COMPLEX WITH ZARDAVERINE
REMARK 900 RELATED ID: 1XOS RELATED DB: PDB
REMARK 900 PDE4B IN COMPLEX WITH SILDENAFIL
REMARK 900 RELATED ID: 1XOZ RELATED DB: PDB
REMARK 900 PDE5A IN COMPLEX WITH TADALAFIL
REMARK 900 RELATED ID: 1XP0 RELATED DB: PDB
REMARK 900 PDE5A IN COMPLEX WITH VARDENAFIL
DBREF 1XOT A 152 528 UNP Q07343 PDE4B_HUMAN 324 700
DBREF 1XOT B 152 528 UNP Q07343 PDE4B_HUMAN 324 700
SEQADV 1XOT MET A 131 UNP Q07343 INITIATING METHIONINE
SEQADV 1XOT GLY A 132 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER A 133 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER A 134 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT HIS A 135 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS A 136 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS A 137 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS A 138 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS A 139 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS A 140 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT SER A 141 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER A 142 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT GLY A 143 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT LEU A 144 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT VAL A 145 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT PRO A 146 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT ARG A 147 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT GLY A 148 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER A 149 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT HIS A 150 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT MET A 151 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT CME A 194 UNP Q07343 CYS 366 MODIFIED RESIDUE
SEQADV 1XOT MET B 131 UNP Q07343 INITIATING METHIONINE
SEQADV 1XOT GLY B 132 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER B 133 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER B 134 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT HIS B 135 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS B 136 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS B 137 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS B 138 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS B 139 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT HIS B 140 UNP Q07343 EXPRESSION TAG
SEQADV 1XOT SER B 141 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER B 142 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT GLY B 143 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT LEU B 144 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT VAL B 145 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT PRO B 146 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT ARG B 147 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT GLY B 148 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT SER B 149 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT HIS B 150 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT MET B 151 UNP Q07343 CLONING ARTIFACT
SEQADV 1XOT CME B 194 UNP Q07343 CYS 366 MODIFIED RESIDUE
SEQRES 1 B 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY
SEQRES 2 B 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE
SEQRES 3 B 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU
SEQRES 4 B 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN
SEQRES 5 B 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE
SEQRES 6 B 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR
SEQRES 7 B 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET
SEQRES 8 B 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS
SEQRES 9 B 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS
SEQRES 10 B 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR
SEQRES 11 B 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE
SEQRES 12 B 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU
SEQRES 13 B 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP
SEQRES 14 B 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE
SEQRES 15 B 398 LYS LEU LEU GLN GLU GLU HIS CYS ASP ILE PHE MET ASN
SEQRES 16 B 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL
SEQRES 17 B 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET
SEQRES 18 B 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS
SEQRES 19 B 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR
SEQRES 20 B 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS
SEQRES 21 B 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR
SEQRES 22 B 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN
SEQRES 23 B 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER
SEQRES 24 B 398 PRO MET CYS ASP LYS HIS THR ALA SER VAL GLU LYS SER
SEQRES 25 B 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP
SEQRES 26 B 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP
SEQRES 27 B 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN
SEQRES 28 B 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU
SEQRES 29 B 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN
SEQRES 30 B 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO
SEQRES 31 B 398 GLU LYS GLU GLY GLU GLY HIS SER
SEQRES 1 A 398 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY
SEQRES 2 A 398 LEU VAL PRO ARG GLY SER HIS MET SER ILE SER ARG PHE
SEQRES 3 A 398 GLY VAL ASN THR GLU ASN GLU ASP HIS LEU ALA LYS GLU
SEQRES 4 A 398 LEU GLU ASP LEU ASN LYS TRP GLY LEU ASN ILE PHE ASN
SEQRES 5 A 398 VAL ALA GLY TYR SER HIS ASN ARG PRO LEU THR CME ILE
SEQRES 6 A 398 MET TYR ALA ILE PHE GLN GLU ARG ASP LEU LEU LYS THR
SEQRES 7 A 398 PHE ARG ILE SER SER ASP THR PHE ILE THR TYR MET MET
SEQRES 8 A 398 THR LEU GLU ASP HIS TYR HIS SER ASP VAL ALA TYR HIS
SEQRES 9 A 398 ASN SER LEU HIS ALA ALA ASP VAL ALA GLN SER THR HIS
SEQRES 10 A 398 VAL LEU LEU SER THR PRO ALA LEU ASP ALA VAL PHE THR
SEQRES 11 A 398 ASP LEU GLU ILE LEU ALA ALA ILE PHE ALA ALA ALA ILE
SEQRES 12 A 398 HIS ASP VAL ASP HIS PRO GLY VAL SER ASN GLN PHE LEU
SEQRES 13 A 398 ILE ASN THR ASN SER GLU LEU ALA LEU MET TYR ASN ASP
SEQRES 14 A 398 GLU SER VAL LEU GLU ASN HIS HIS LEU ALA VAL GLY PHE
SEQRES 15 A 398 LYS LEU LEU GLN GLU GLU HIS CYS ASP ILE PHE MET ASN
SEQRES 16 A 398 LEU THR LYS LYS GLN ARG GLN THR LEU ARG LYS MET VAL
SEQRES 17 A 398 ILE ASP MET VAL LEU ALA THR ASP MET SER LYS HIS MET
SEQRES 18 A 398 SER LEU LEU ALA ASP LEU LYS THR MET VAL GLU THR LYS
SEQRES 19 A 398 LYS VAL THR SER SER GLY VAL LEU LEU LEU ASP ASN TYR
SEQRES 20 A 398 THR ASP ARG ILE GLN VAL LEU ARG ASN MET VAL HIS CYS
SEQRES 21 A 398 ALA ASP LEU SER ASN PRO THR LYS SER LEU GLU LEU TYR
SEQRES 22 A 398 ARG GLN TRP THR ASP ARG ILE MET GLU GLU PHE PHE GLN
SEQRES 23 A 398 GLN GLY ASP LYS GLU ARG GLU ARG GLY MET GLU ILE SER
SEQRES 24 A 398 PRO MET CYS ASP LYS HIS THR ALA SER VAL GLU LYS SER
SEQRES 25 A 398 GLN VAL GLY PHE ILE ASP TYR ILE VAL HIS PRO LEU TRP
SEQRES 26 A 398 GLU THR TRP ALA ASP LEU VAL GLN PRO ASP ALA GLN ASP
SEQRES 27 A 398 ILE LEU ASP THR LEU GLU ASP ASN ARG ASN TRP TYR GLN
SEQRES 28 A 398 SER MET ILE PRO GLN SER PRO SER PRO PRO LEU ASP GLU
SEQRES 29 A 398 GLN ASN ARG ASP CYS GLN GLY LEU MET GLU LYS PHE GLN
SEQRES 30 A 398 PHE GLU LEU THR LEU ASP GLU GLU ASP SER GLU GLY PRO
SEQRES 31 A 398 GLU LYS GLU GLY GLU GLY HIS SER
MODRES 1XOT CME B 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE
MODRES 1XOT CME A 194 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE
HET CME B 194 10
HET CME A 194 10
HET ZN B1001 1
HET MG B1002 1
HET VDN B 102 34
HET ZN A1001 1
HET MG A1002 1
HET VDN A 101 34
HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE
HETNAM ZN ZINC ION
HETNAM MG MAGNESIUM ION
HETNAM VDN 2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-
HETNAM 2 VDN 5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-
HETNAM 3 VDN ONE
HETSYN VDN VARDENAFIL, LEVITRA
FORMUL 1 CME 2(C5 H11 N O3 S2)
FORMUL 3 ZN 2(ZN 2+)
FORMUL 4 MG 2(MG 2+)
FORMUL 5 VDN 2(C23 H32 N6 O4 S)
FORMUL 9 HOH *46(H2 O)
HELIX 1 1 GLU B 163 LEU B 170 1 8
HELIX 2 2 GLU B 171 LEU B 173 5 3
HELIX 3 3 ASN B 179 TYR B 186 1 8
HELIX 4 4 ARG B 190 ARG B 203 1 14
HELIX 5 5 ASP B 204 PHE B 209 1 6
HELIX 6 6 SER B 212 HIS B 226 1 15
HELIX 7 7 ASN B 235 LEU B 250 1 16
HELIX 8 8 SER B 251 ASP B 256 5 6
HELIX 9 9 THR B 260 HIS B 274 1 15
HELIX 10 10 SER B 282 THR B 289 1 8
HELIX 11 11 SER B 291 ASN B 298 1 8
HELIX 12 12 SER B 301 LEU B 314 1 14
HELIX 13 13 GLU B 317 ASP B 321 5 5
HELIX 14 14 THR B 327 ALA B 344 1 18
HELIX 15 15 THR B 345 SER B 348 5 4
HELIX 16 16 LYS B 349 THR B 363 1 15
HELIX 17 17 ASN B 376 LEU B 393 1 18
HELIX 18 18 SER B 394 LYS B 398 5 5
HELIX 19 19 SER B 399 GLY B 425 1 27
HELIX 20 20 SER B 438 ILE B 450 1 13
HELIX 21 21 ILE B 450 VAL B 462 1 13
HELIX 22 22 ALA B 466 ILE B 484 1 19
HELIX 23 23 GLU A 163 GLU A 171 1 9
HELIX 24 24 ASN A 179 SER A 187 1 9
HELIX 25 25 ARG A 190 ARG A 203 1 14
HELIX 26 26 ASP A 204 PHE A 209 1 6
HELIX 27 27 SER A 212 TYR A 227 1 16
HELIX 28 28 ASN A 235 LEU A 250 1 16
HELIX 29 29 SER A 251 ASP A 256 5 6
HELIX 30 30 THR A 260 HIS A 274 1 15
HELIX 31 31 SER A 282 THR A 289 1 8
HELIX 32 32 SER A 291 TYR A 297 1 7
HELIX 33 33 SER A 301 LEU A 314 1 14
HELIX 34 34 LEU A 315 GLN A 316 5 2
HELIX 35 35 GLU A 317 ASP A 321 5 5
HELIX 36 36 THR A 327 ALA A 344 1 18
HELIX 37 37 THR A 345 SER A 348 5 4
HELIX 38 38 LYS A 349 THR A 363 1 15
HELIX 39 39 ASN A 376 LEU A 393 1 18
HELIX 40 40 SER A 394 LYS A 398 5 5
HELIX 41 41 SER A 399 GLY A 425 1 27
HELIX 42 42 SER A 438 ILE A 450 1 13
HELIX 43 43 ILE A 450 VAL A 462 1 13
HELIX 44 44 ALA A 466 MET A 483 1 18
LINK C THR B 193 N CME B 194 1555 1555 1.32
LINK C CME B 194 N ILE B 195 1555 1555 1.35
LINK C THR A 193 N CME A 194 1555 1555 1.32
LINK C CME A 194 N ILE A 195 1555 1555 1.34
LINK NE2 HIS B 238 ZN ZN B1001 1555 1555 2.34
LINK NE2 HIS B 274 ZN ZN B1001 1555 1555 2.08
LINK OD2 ASP B 275 ZN ZN B1001 1555 1555 2.25
LINK OD1 ASP B 275 MG MG B1002 1555 1555 2.11
LINK OD2 ASP B 392 ZN ZN B1001 1555 1555 2.18
LINK ZN ZN B1001 O HOH B2007 1555 1555 2.05
LINK ZN ZN B1001 O HOH B2008 1555 1555 2.11
LINK MG MG B1002 O HOH B2003 1555 1555 2.14
LINK MG MG B1002 O HOH B2004 1555 1555 2.14
LINK MG MG B1002 O HOH B2005 1555 1555 2.05
LINK MG MG B1002 O HOH B2006 1555 1555 2.25
LINK MG MG B1002 O HOH B2007 1555 1555 1.93
LINK NE2 HIS A 238 ZN ZN A1001 1555 1555 2.40
LINK NE2 HIS A 274 ZN ZN A1001 1555 1555 2.26
LINK OD2 ASP A 275 ZN ZN A1001 1555 1555 2.33
LINK OD1 ASP A 275 MG MG A1002 1555 1555 2.02
LINK OD2 ASP A 392 ZN ZN A1001 1555 1555 1.95
LINK ZN ZN A1001 O HOH A1007 1555 1555 2.12
LINK ZN ZN A1001 O HOH A1008 1555 1555 1.77
LINK MG MG A1002 O HOH A1003 1555 1555 2.21
LINK MG MG A1002 O HOH A1004 1555 1555 1.89
LINK MG MG A1002 O HOH A1005 1555 1555 2.09
LINK MG MG A1002 O HOH A1006 1555 1555 2.08
LINK MG MG A1002 O HOH A1007 1555 1555 2.02
CISPEP 1 GLN B 463 PRO B 464 0 1.40
CISPEP 2 GLN A 463 PRO A 464 0 -2.72
SITE 1 AC1 6 HIS A 238 HIS A 274 ASP A 275 ASP A 392
SITE 2 AC1 6 HOH A1007 HOH A1008
SITE 1 AC2 6 ASP A 275 HOH A1003 HOH A1004 HOH A1005
SITE 2 AC2 6 HOH A1006 HOH A1007
SITE 1 AC3 6 HIS B 238 HIS B 274 ASP B 275 ASP B 392
SITE 2 AC3 6 HOH B2007 HOH B2008
SITE 1 AC4 6 ASP B 275 HOH B2003 HOH B2004 HOH B2005
SITE 2 AC4 6 HOH B2006 HOH B2007
SITE 1 AC5 13 HOH A 27 TYR A 233 HIS A 234 MET A 347
SITE 2 AC5 13 ASN A 395 MET A 411 SER A 429 MET A 431
SITE 3 AC5 13 SER A 442 GLN A 443 PHE A 446 HOH A1006
SITE 4 AC5 13 HOH A1008
SITE 1 AC6 14 HOH B 2 HOH B 30 TYR B 233 HIS B 234
SITE 2 AC6 14 MET B 347 ASN B 395 ILE B 410 MET B 411
SITE 3 AC6 14 SER B 429 MET B 431 SER B 442 GLN B 443
SITE 4 AC6 14 PHE B 446 HOH B2008
CRYST1 89.841 94.423 108.755 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011131 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010591 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009195 0.00000